| 000 | 01739 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515124320.0 | ||
| 264 | 0 | _c20080731 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1091-6490 | ||
| 024 | 7 |
_a10.1073/pnas.0803513105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurgess, Darren J | |
| 245 | 0 | 0 |
_aTopoisomerase levels determine chemotherapy response in vitro and in vivo. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cJul 2008 |
||
| 300 |
_a9053-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xmetabolism |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xmetabolism |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPoly-ADP-Ribose Binding Proteins |
| 650 | 0 | 4 |
_aRNA Interference _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aDoles, Jason | |
| 700 | 1 | _aZender, Lars | |
| 700 | 1 | _aXue, Wen | |
| 700 | 1 | _aMa, Beicong | |
| 700 | 1 | _aMcCombie, W Richard | |
| 700 | 1 | _aHannon, Gregory J | |
| 700 | 1 | _aLowe, Scott W | |
| 700 | 1 | _aHemann, Michael T | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 105 _gno. 26 _gp. 9053-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.0803513105 _zAvailable from publisher's website |
| 999 |
_c18058191 _d18058191 |
||